Richard W Mott's Net Worth
$24.5 Million
Who is Richard W Mott?
Richard W Mott has an estimated net worth of $24.5 Million. This is based on reported shares across multiple companies, which include KYPHON INC, TREACE MEDICAL CONCEPTS, INC., Lyra Therapeutics, Inc., and ENDOLOGIX INC /DE/.
SEC CIK
Richard W Mott's CIK is 0001210226
Past Insider Trading and Trends
2004 was Richard W Mott's most active year for acquiring shares with 11 total transactions. Richard W Mott's most active month to acquire stocks was the month of April. 2004 was Richard W Mott's most active year for disposing of shares, totalling 21 transactions. Richard W Mott's most active month to dispose stocks was the month of December. 2024 saw Richard W Mott paying a total of $694,864.48 for 198,451 shares, this is the most they've acquired in one year. In 2007 Richard W Mott cashed out on 1,175,000 shares for a total of $59,232,250.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
KYPHON INC No price found
President, CEO and Director
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
$19.27 | -$263,800.00 |
0
|
Scheduled
|
May 16
| ||
Form 4
|
—
|
0
|
$18.92 | -$250,000.00 |
0
|
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$18.85 | -$123,500.00 |
0
|
Scheduled
|
Mar 7
| ||
Form 4
|
—
|
0
|
$18.66 | -$119,700.00 |
0
|
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$19.81 | -$285,400.00 |
0
|
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$18.92 | -$124,900.00 |
0
|
Scheduled
|
Jan 19
| ||
Form 4
|
—
|
0
|
$19.02 | -$127,000.00 |
0
|
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$18.98 | -$126,100.00 |
0
|
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
$18.29 | -$112,400.00 |
0
|
Scheduled
|
Dec 1
| ||
Form 4
|
—
|
0
|
$18.79 | -$244,500.00 |
0
|
Scheduled
|
Nov 15
| ||
Form 4
|
—
|
0
|
$18.99 | -$252,800.00 |
0
|
Scheduled
|
Oct 6
| ||
Form 4
|
—
|
0
|
$18.84 | -$123,300.00 |
0
|
Scheduled
|
Sep 21
| ||
Form 4
|
—
|
0
|
$18.13 | -$109,100.00 |
0
|
Scheduled
|
Sep 3
| ||
Form 4
|
—
|
0
|
$19.65 | -$279,200.00 |
0
|
Scheduled
|
Aug 2
| ||
Form 4
|
—
|
0
|
$20.11 | -$297,600.00 |
0
|
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
$18.93 | -$125,300.00 |
0
|
Scheduled
|
Jun 14 - Jun 15
| ||
Form 4
|
—
|
0
|
$18.50 | -$116,500.00 |
0
|
Scheduled
|
Jun 7
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TREACE MEDICAL CONCEPTS, INC. (TMCI) Snapshot price: $5.33
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.71% | 18K |
$5.19 | $93,501.00 | 1.07M |
May 24
| |||
Form 4
| +1.16% | 12.1K |
$4.99 | $60,424.98 | 1.05M |
May 22
| |||
Form 4
| +1.47% | 15.09K |
—
|
—
| 1.04M |
May 21
| |||
Form 4
| +13.22% | 120K |
$4.51 | $540,938.50 | 1.03M |
May 10 - May 13
| |||
Form 4
| +0.30% | 2.75K |
—
|
—
| 907.75K |
May 23
| |||
Form 4
| -0.44% | -4.04K |
$26.00 | -$105,121.23 | 905K |
Apr 6
| |||
Form 4
| -1.73% | -15.96K |
$26.00 | -$414,893.03 | 909.04K |
Apr 3 - Apr 4
| |||
Form 4
| -12.61% | -133.50K |
$25.54 | -$3,410,027.05 | 925K |
Mar 30 - Mar 31
| |||
Form 4
| -4.21% | -46.50K |
$23.26 | -$1,081,554.00 | 1.06M |
Scheduled
|
Mar 8 - Mar 9
| ||
Form 4
| -4.33% | -50.00K |
$21.35 | -$1,067,545.00 | 1.1M |
Scheduled
|
Mar 1
| ||
Form 4
| -0.35% | -4.01K |
$24.00 | -$96,264.00 | 1.16M |
Scheduled
|
Feb 2
| ||
Form 4
| -7.28% | -90.99K |
$23.25 | -$2,115,171.40 | 1.16M |
Scheduled
|
Jan 30
| ||
Form 4
| -0.87% | -11.01K |
$26.00 | -$286,377.22 | 1.25M |
Scheduled
|
Jan 17
| ||
Form 4
| -3.74% | -48.99K |
$26.00 | -$1,273,662.13 | 1.26M |
Scheduled
|
Jan 12 - Jan 13
| ||
Form 4
| -1.50% | -20.00K |
$24.00 | -$480,040.00 | 1.31M |
Scheduled
|
Jan 5 - Jan 9
| ||
Form 4
| -5.34% | -75.00K |
$22.67 | -$1,700,422.50 | 1.33M |
Scheduled
|
Dec 30
| ||
Form 4
| -6.33% | -95.00K |
$22.35 | -$2,122,800.00 | 1.41M |
Scheduled
|
Nov 30 - Dec 1
| ||
Form 4
| -5.96% | -95.00K |
$23.57 | -$2,238,931.50 | 1.5M |
Scheduled
|
Oct 31
| ||
Form 4
| +0.14% | 2.29K |
—
|
—
| 1.59M |
May 17
| |||
Form 4
| -6.18% | -105.00K |
—
|
—
| 1.59M |
Mar 10
| |||
Form 4
| +70.01% | 699.14K |
—
|
—
| 1.7M |
Apr 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Lyra Therapeutics, Inc. (LYRA) Snapshot price: $0.2798
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDOLOGIX INC /DE/ No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||